Barx2tm1Rsd/Barx2tm1Rsd Dmdmdx/Y
involves: 129 * C57BL/6 * C57BL/10ScSn
|
abnormal diaphragm morphology |
J:187799
|
abnormal gait |
J:187799
|
decreased body size |
J:187799
|
decreased locomotor activity |
J:187799
|
decreased muscle weight |
J:187799
|
impaired skeletal muscle regeneration |
J:187799
|
increased variability of skeletal muscle fiber size |
J:187799
|
kyphosis |
J:187799
|
postnatal lethality, incomplete penetrance |
J:187799
|
progressive muscle weakness |
J:187799
|
skeletal muscle endomysial fibrosis |
J:187799
|
skeletal muscle fiber necrosis |
J:187799
|
skeletal muscle fibrosis |
J:187799
|
thin diaphragm muscle |
J:187799
|
Barx2tm1Rsd/Barx2tm1Rsd Dmdmdx/Dmdmdx
involves: 129 * C57BL/6 * C57BL/10ScSn
|
abnormal diaphragm morphology |
J:187799
|
abnormal gait |
J:187799
|
decreased body size |
J:187799
|
decreased locomotor activity |
J:187799
|
decreased muscle weight |
J:187799
|
impaired skeletal muscle regeneration |
J:187799
|
increased variability of skeletal muscle fiber size |
J:187799
|
kyphosis |
J:187799
|
postnatal lethality, incomplete penetrance |
J:187799
|
progressive muscle weakness |
J:187799
|
skeletal muscle endomysial fibrosis |
J:187799
|
skeletal muscle fiber necrosis |
J:187799
|
skeletal muscle fibrosis |
J:187799
|
thin diaphragm muscle |
J:187799
|
Cav3tm1Ncnp/Cav3+ Dmdmdx/Dmdmdx
involves: 129S4/SvJae * C57BL/10 * C57BL/10ScSn
|
abnormal intercostal muscle morphology |
J:150127
|
abnormal muscle development |
J:150127
|
abnormal muscle fiber morphology |
J:150127
|
centrally nucleated skeletal muscle fibers |
J:150127
|
Cmahtm1Avrk/Cmahtm1Avrk Dmdmdx/Dmdmdx
involves: 129X1/SvJ * C57BL/10ScSn
|
abnormal gait |
J:164594
|
cardiac muscle necrosis |
J:164594
|
dystrophic muscle |
J:164594
|
impaired coordination |
J:164594
|
increased macrophage cell number |
J:164594
|
increased monocyte cell number |
J:164594
|
muscle weakness |
J:164594
|
premature death |
J:164594
|
skeletal muscle fibrosis |
J:164594
|
Creb1tm1.1Berd/Creb1tm1.1Berd Dmdmdx/Y
B.Cg-Creb1tm1.1Berd Dmdmdx
|
enhanced skeletal muscle regeneration |
J:177923
|
skeletal muscle degeneration |
J:177923
|
Ctsstm1Hap/Ctsstm1Hap Dmdmdx/Dmdmdx
involves: 129S2/SvPas * C57BL/10ScSn
|
abnormal skeletal muscle fiber morphology |
J:230788
|
centrally nucleated skeletal muscle fibers |
J:230788
|
dystrophic muscle |
J:230788
|
impaired exercise endurance |
J:230788
|
increased circulating creatine kinase level |
J:230788
|
skeletal muscle fiber necrosis |
J:230788
|
skeletal muscle fibrosis |
J:230788
|
Dag1tm1.1Swin/Dag1tm1.1Swin Dmdmdx/Y
involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn
|
centrally nucleated skeletal muscle fibers |
J:187750
|
increased circulating creatine kinase level |
J:187750
|
increased susceptibility to injury |
J:187750
|
Dag1tm1.1Swin/Dag1tm1.1Swin Dmdmdx/Dmdmdx
involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn
|
centrally nucleated skeletal muscle fibers |
J:187750
|
increased circulating creatine kinase level |
J:187750
|
increased susceptibility to injury |
J:187750
|
Dmdmdx-3Cv/Dmdmdx-3Cv Utrntm1Ked/Utrntm1Ked
involves: 129 * C3H/HeHa * C57BL * M. m. castaneus * M. m. musculus
|
abnormal skeletal muscle morphology |
J:116348
|
normal
liver/biliary system phenotype |
J:116348
|
normal
nervous system phenotype |
J:116348
|
normal
renal/urinary system phenotype |
J:116348
|
normal
reproductive system phenotype |
J:116348
|
normal
respiratory system phenotype |
J:116348
|
Dmdmdx-3Cv/Y Utrntm1Ked/Utrntm1Ked
involves: 129 * C3H/HeHa * C57BL * M. m. castaneus * M. m. musculus
|
abnormal skeletal muscle morphology |
J:116348
|
normal
liver/biliary system phenotype |
J:116348
|
normal
nervous system phenotype |
J:116348
|
normal
renal/urinary system phenotype |
J:116348
|
normal
reproductive system phenotype |
J:116348
|
normal
respiratory system phenotype |
J:116348
|
Dmdmdx-4Cv/Dmdmdx-4Cv Myf5tm2Tajb/Myf5tm2Tajb
involves: 129S2/SvPas * C3H/HeHa * C57BL * M. m. castaneus * M. m. musculus
|
increased skeletal muscle fiber diameter |
J:128921
|
skeletal muscle fiber necrosis |
J:128921
|
Dmdmdx-4Cv/Dmdmdx-4Cv Terctm1Rdp/Terctm1Rdp
B6.Cg-Terctm1Rdp Dmdmdx-4Cv
|
abnormal mitochondrial shape |
J:200365
|
abnormal myocardial fiber morphology |
J:200365
|
cardiac fibrosis |
J:200365
|
decreased heart ventricle muscle contractility |
J:200365
|
decreased mitochondrial size |
J:200365
|
decreased telomere length |
J:200365
|
dilated cardiomyopathy |
J:200365
|
dilated heart left ventricle |
J:200365
|
disorganized mitochondrial cristae |
J:200365
|
increased heart left ventricle size |
J:200365
|
increased mitochondrial number |
J:200365
|
oxidative stress |
J:200365
|
premature death |
J:200365
|
prolonged QRS complex duration |
J:200365
|
ventricular cardiomyopathy |
J:200365
|
Dmdmdx-5Cv/Dmdmdx-5Cv Flt1tm1Jrt/Flt1+
involves: C3HA * C57BL/6Ros
|
abnormal blood circulation |
J:164891
|
abnormal muscle contractility |
J:164891
|
abnormal muscle development |
J:164891
|
abnormal skeletal muscle fiber morphology |
J:164891
|
abnormal skeletal muscle fiber size |
J:164891
|
increased capillary density |
J:164891
|
increased satellite cell number |
J:164891
|
normal
muscle phenotype |
J:164891
|
Dmdmdx-5Cv/Dmdmdx-5Cv Flt1tm1Jrt/Flt1+ Utrntm1Jrs/Utrntm1Jrs
involves: 129S1/Sv * 129X1/SvJ * C3HA * C57BL/6Ros
|
centrally nucleated skeletal muscle fibers |
J:164891
|
extended life span |
J:164891
|
increased body weight |
J:164891
|
Dmdmdx/Dmd+ Nos1tm1Plh/Nos1tm1Plh
involves: 129S4/SvJae * C57BL/10ScSn
|
abnormal circulating pyruvate kinase level |
J:48851
|
dystrophic muscle |
J:48851
|
Dmdmdx/Dmd+ Foxk1tm1Djg/Foxk1+
involves: 129S4/SvJae * C57BL/10ScSn
|
decreased body size |
J:62225
|
skeletal muscle necrosis |
J:62225
|
Dmdmdx/Dmdmdx Dusp1tm1Brv/Dusp1tm1Brv
involves: 129S2/SvPas * C57BL/6 * C57BL/10ScSn
|
decreased body size |
J:162340
|
decreased body weight |
J:162340
|
decreased grip strength |
J:162340
|
decreased skeletal muscle fiber diameter |
J:162340
|
decreased skeletal muscle fiber size |
J:162340
|
decreased skeletal muscle weight |
J:162340
|
dystrophic muscle |
J:162340
|
myositis |
J:162340
|
skeletal muscle fiber degeneration |
J:162340
|
Dmdmdx/Dmdmdx Foxk1tm1Djg/Foxk1tm1Djg
involves: 129S4/SvJae * C57BL/10ScSn
|
decreased locomotor activity |
J:62225
|
postnatal lethality, incomplete penetrance |
J:62225
|
premature death |
J:62225
|
skeletal muscle fibrosis |
J:62225
|
skeletal muscle necrosis |
J:62225
|
weakness |
J:62225
|
Dmdmdx/Dmdmdx Mamstrtm1.2Eno/Mamstrtm1.2Eno
involves: 129 * C57BL/6 * C57BL/10ScSn
|
abnormal skeletal muscle satellite cell proliferation |
J:179880
|
decreased body weight |
J:179880
|
decreased skeletal muscle weight |
J:179880
|
muscle degeneration |
J:179880
|
skeletal muscle fibrosis |
J:179880
|
Dmdmdx/Dmdmdx Mmp9tm1Tvu/Mmp9+
B10.Cg-Mmp9tm1Tvu Dmdmdx
|
abnormal muscle morphology |
J:150030
|
abnormal muscle physiology |
J:150030
|
decreased macrophage cell number |
J:150030
|
enhanced skeletal muscle regeneration |
J:150030
|
Dmdmdx/Dmdmdx Mmp9tm1Tvu/Mmp9tm1Tvu
B10.Cg-Mmp9tm1Tvu Dmdmdx
|
abnormal muscle morphology |
J:150030
|
decreased macrophage cell number |
J:150030
|
enhanced skeletal muscle regeneration |
J:150030
|
Dmdmdx/Dmdmdx Prkdcscid/Prkdcscid
involves: BALB/c * C57BL/10ScSn * C57BL/Ka
|
abnormal vertebral column morphology |
J:125527
|
absent CD4-positive, alpha-beta T cells |
J:125527
|
absent CD8-positive, alpha-beta T cells |
J:125527
|
centrally nucleated skeletal muscle fibers |
J:125527
|
decreased B cell number |
J:125527
|
decreased transforming growth factor beta level |
J:125527
|
impaired exercise endurance |
J:125527
|
impaired skeletal muscle contractility |
J:125527
|
increased skeletal muscle fiber diameter |
J:125527
|
reduced fertility |
J:125527
|
skeletal muscle fiber degeneration |
J:125527
|
skeletal muscle fibrosis |
J:125527
|
Dmdmdx/Dmdmdx Selenostm1.1Sfa/Selenos+
involves: C57BL/6 * C57BL/10ScSn
|
abnormal respiratory quotient |
J:266872
|
abnormal skeletal muscle fiber type ratio |
J:266872
|
decreased body mass index |
J:266872
|
decreased lean body mass |
J:266872
|
increased carbon dioxide production |
J:266872
|
increased oxygen consumption |
J:266872
|
normal
muscle phenotype |
J:266872
|
Dmdmdx/Dmdmdx Snhg15tm1Nju/Snhg15tm1Nju
involves: C57BL/6J * C57BL/10ScSn
|
normal
growth/size/body region phenotype |
J:291983
|
impaired skeletal muscle regeneration |
J:291983
|
increased variability of skeletal muscle fiber size |
J:291983
|
normal
muscle phenotype |
J:291983
|
skeletal muscle fibrosis |
J:291983
|
Dmdmdx/Dmdmdx Spp1tm1Blh/Spp1tm1Blh
involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn
|
abnormal muscle physiology |
J:150572
|
abnormal physical strength |
J:150572
|
decreased granulocyte number |
J:150572
|
decreased neutrophil cell number |
J:150572
|
decreased T cell number |
J:150572
|
increased regulatory T cell number |
J:150572
|
increased T cell number |
J:150572
|
Dmdmdx/Dmdmdx Tg(ACTA1-SSPN)3.0Rcros/0
involves: C57BL/10ScSn
|
abnormal sarcolemma morphology |
J:185346
|
centrally nucleated skeletal muscle fibers |
J:185346
|
dystrophic muscle |
J:185346
|
Dmdmdx/Dmdmdx Utrntm1Jrs/Utrntm1Jrs
involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn
|
abnormal gait |
J:42389
|
abnormal limb morphology |
J:42389,
J:59675
|
abnormal muscle physiology |
J:42389
|
abnormal muscle relaxation |
J:42389
|
abnormal neuromuscular synapse morphology |
J:42389,
J:60776
|
cardiomyopathy |
J:42389,
J:59675
|
decreased body size |
J:42389
|
dystrophic muscle |
J:42389,
J:59675
|
kyphosis |
J:42389,
J:59675
|
muscle degeneration |
J:42389
|
muscle weakness |
J:42389
|
myocardium necrosis |
J:42389
|
postnatal growth retardation |
J:42389,
J:59675
|
premature death |
J:42389,
J:59675
|
skeletal muscle interstitial fibrosis |
J:42389
|
skeletal muscle necrosis |
J:42389
|
Dmdmdx/Dmdmdx Utrntm1Ked/Utrntm1Ked
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10ScSn * DBA
|
abnormal breathing pattern |
J:42388
|
abnormal gait |
J:42388
|
abnormal hindlimb morphology |
J:42388
|
abnormal neuromuscular synapse morphology |
J:42388
|
abnormal posture |
J:42388
|
abnormal skeletal muscle fiber morphology |
J:42388
|
abnormal skeletal muscle fiber size |
J:42388
|
centrally nucleated skeletal muscle fibers |
J:42388
|
decreased locomotor activity |
J:42388
|
dystrophic muscle |
J:42388
|
kyphosis |
J:42388
|
premature death |
J:42388
|
progressive muscle weakness |
J:42388
|
skeletal muscle interstitial fibrosis |
J:42388
|
skeletal muscle necrosis |
J:42388
|
weight loss |
J:42388
|
Dmdmdx/Y Dtnatm1Jrs/Dtnatm1Jrs
involves: 129X1/SvJ * C57BL/10ScSn
|
abnormal neuromuscular synapse morphology |
J:60776
|
cardiomyopathy |
J:59675
|
dystrophic muscle |
J:59675
|
premature death |
J:59675
|
Dmdmdx/Y Dtnatm1Jrs/Dtnatm1Jrs Utrntm1Jrs/Utrntm1Jrs
involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn
|
abnormal limb morphology |
J:59675
|
abnormal neuromuscular synapse morphology |
J:60776
|
cardiomyopathy |
J:59675
|
dystrophic muscle |
J:59675
|
kyphosis |
J:59675
|
postnatal growth retardation |
J:59675
|
postnatal lethality, incomplete penetrance |
J:59675
|
premature death |
J:59675
|
skeletal muscle necrosis |
J:59675
|
Dmdmdx/? Fgf2tm1Zllr/Fgf2tm1Zllr
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10ScSn
|
dystrophic muscle |
J:85088
|
Dmdmdx/? Fgf2tm1Zllr/Fgf2tm1Zllr Fgf6tm1Thbr/Fgf6tm1Thbr
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * C57BL/10ScSn
|
abnormal muscle physiology |
J:85088
|
abnormal skeletal muscle fiber morphology |
J:85088
|
abnormal skeletal muscle morphology |
J:85088
|
abnormal spine curvature |
J:85088
|
decreased satellite cell number |
J:85088
|
dystrophic muscle |
J:85088
|
increased variability of skeletal muscle fiber size |
J:85088
|
normal
muscle phenotype |
J:85088
|
skeletal muscle fiber necrosis |
J:85088
|
Dmdmdx/? Fgf6tm1Thbr/Fgf6tm1Thbr
involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn
|
abnormal diaphragm morphology |
J:42574
|
abnormal epaxial muscle morphology |
J:42574
|
abnormal hypaxial muscle morphology |
J:42574
|
abnormal spine curvature |
J:42574
|
dystrophic muscle |
J:85088
|
normal
muscle phenotype |
J:42574
|
myopathy |
J:42574
|
Dmdmdx/Y Foxk1tm1Djg/Foxk1tm1Djg
involves: 129S4/SvJae * C57BL/10ScSn
|
decreased locomotor activity |
J:62225
|
postnatal lethality, incomplete penetrance |
J:62225
|
premature death |
J:62225
|
skeletal muscle fibrosis |
J:62225
|
skeletal muscle necrosis |
J:62225
|
weakness |
J:62225
|
Dmdmdx/Y Foxn1nu/Foxn1nu
involves: C57BL/10ScSn
|
abnormal muscle morphology |
J:95776
|
decreased skeletal muscle fiber size |
J:95776
|
increased skeletal muscle fiber size |
J:95776
|
Dmdmdx/Y Mirc37tm1Boet/Mirc37tm1Boet
involves: C57BL/10ScSn
|
dystrophic muscle |
J:241493
|
increased creatine kinase activity |
J:241493
|
Dmdmdx/? Myod1tm1Jae/Myod1tm1Jae
involves: 129S4/SvJae * C57BL/10ScSn
|
abnormal heart ventricle morphology |
J:52248
|
cardiac fibrosis |
J:52248
|
cardiac interstitial fibrosis |
J:52248
|
dilated cardiomyopathy |
J:52248
|
increased heart weight |
J:52248
|
increased myocardial fiber size |
J:52248
|
myocardium necrosis |
J:52248
|
premature death |
J:52248
|
Dmdmdx/Y Nos1tm1Plh/Nos1tm1Plh
involves: 129S4/SvJae * C57BL/10ScSn
|
abnormal circulating pyruvate kinase level |
J:48851
|
dystrophic muscle |
J:48851
|
Dmdmdx/Y Spp1tm1Blh/Spp1tm1Blh
involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn
|
abnormal muscle physiology |
J:150572
|
abnormal physical strength |
J:150572
|
decreased granulocyte number |
J:150572
|
decreased neutrophil cell number |
J:150572
|
decreased T cell number |
J:150572
|
increased regulatory T cell number |
J:150572
|
increased T cell number |
J:150572
|
Dmdmdx/Y Terctm1Rdp/Terc+
involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL
|
abnormal diaphragm morphology |
J:167294
|
abnormal muscle physiology |
J:167294
|
centrally nucleated skeletal muscle fibers |
J:167294
|
increased circulating creatine kinase level |
J:167294
|
Dmdmdx/Y Terctm1Rdp/Terctm1Rdp
involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL
|
abnormal diaphragm morphology |
J:167294
|
abnormal muscle electrophysiology |
J:167294
|
abnormal muscle physiology |
J:167294
|
abnormal skeletal muscle morphology |
J:167294
|
calcified muscle |
J:167294
|
centrally nucleated skeletal muscle fibers |
J:167294
|
chromosomal instability |
J:167294
|
decreased satellite cell number |
J:167294
|
decreased telomere length |
J:167294
|
dystrophic muscle |
J:167294
|
impaired exercise endurance |
J:167294
|
increased circulating creatine kinase level |
J:167294
|
increased variability of skeletal muscle fiber size |
J:167294
|
kyphosis |
J:167294
|
muscle weakness |
J:167294
|
muscular atrophy |
J:167294
|
myositis |
J:167294
|
premature death |
J:167294
|
respiratory failure |
J:167294
|
skeletal muscle degeneration |
J:167294
|
skeletal muscle fibrosis |
J:167294
|
skeletal muscle necrosis |
J:167294
|
Dmdmdx/Y Tg(DMD*)#Spc/0
involves: 129P2/OlaHsd * C57BL/10ScSn * DBA/2
|
abnormal calcium level |
J:280218
|
dystrophic muscle |
J:280218
|
myositis |
J:280218
|
skeletal muscle fibrosis |
J:280218
|
Dmdmdx/Y Utrntm1Jrs/Utrn+
involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn
|
diaphragmitis |
J:140282
|
myositis |
J:140282
|
skeletal muscle endomysial fibrosis |
J:140282
|
Dmdtm1.1Know/Dmdtm1.1Know A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Tg(Myh6-2A)#Know/0
involves: BALB/c * C3H * C57BL/6 * FVB/N
|
abnormal heart echocardiography feature |
J:207775
|
cardiac fibrosis |
J:207775
|
cardiomyopathy |
J:207775
|
decreased susceptibility to injury |
J:207775
|
increased cardiac muscle contractility |
J:207775
|